GleamWall
中文EN

FOFA FAMILY OFFICE OF AMERICA, INC.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1871181 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY47.9%
TTM EPS YoY0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-13.4%
ROA-7.4%
ROIC (approx.)-44.8%
Asset turnover—

Leverage & solvency

Liabilities / assets59.1%
Debt / equity0.00x
Current ratio0.75x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-1.93x
Accruals ratio-21.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$397,764$532,674$783,126—————
Cost of revenue$175,933———————
Gross profit$221,831$532,674$783,126—————
SG&A expense$240,364$673,868$477,648$408,800$26,161$50,508$30,746$29,040
Operating income-$44,481-$154,540$274,872-$243,124-$55,169-$99,318-$103,321-$29,040
Pretax income-$41,362-$125,146$277,474-$243,255-$50,944-$95,228-$103,321-$30,420
Income tax$0$0$68,425—————
Net income-$41,362-$125,146$263,789-$243,255-$50,944-$95,228-$103,321-$30,420
EPS (basic)0.000.000.01—0.000.000.00—
EPS (diluted)0.000.000.01—0.000.000.00—
Weighted avg. shares (diluted)30.85M30.49M38.17M—27.33M26.74M22.59M—
Banking
Net interest income-$1,285-$578-$1,259-$14,140$4,225$4,090—-$1,380
Balance sheet
Cash & equivalents$755,451$636,887$343,220$155,798$827,598$585,273$565,222$13,586
Receivables$184,307$160,909$267,666$74,764————
Current assets$963,736$809,972$668,579$270,359$829,347$588,771$570,468$20,581
Goodwill$1.20M$999,170$999,170$835,600————
Intangibles$882,774$529,250$583,167$437,083————
Total assets$3.35M$2.65M$2.26M$1.54M$588,771$588,771$570,468$20,581
Current liabilities$1.28M$1.21M$787,182$578,533$25,682$34,375$49,654$44,021
Long-term debt—$207,750$507,750$300,000————
Total debt—$207,750$507,750$300,000————
Total liabilities$1.98M$1.65M$1.29M$878,533$25,682$34,375$49,654$44,021
Shareholders' equity$1.37M$997,198$966,111$664,509$803,665$554,396$520,814-$23,440
Net debt—-$429,137$164,530$144,202————
Shares outstanding31.37M30.59M30.30M30.20M29.70M26.99M26.19M20.44M
Cash flow statement
Operating cash flow$67,849$148,667$225,707-$161,200-$17,675-$59,949-$23,364-$33,118
Investing cash flow-$338,285$0-$38,285—————
Financing cash flow$389,000——$50,000$260,000$80,000$575,000$0
Stock-based compensation$16,438$16,438$16,439$36,194$14,270$14,270$72,575—

Free plan shows the latest 8 periods; Pro shows all 23 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.